The ASH ARCH grant supports independent investigators advancing hematology through basic, translational, clinical, or outcomes-based research, with a focus on impact and accessibility.
Funder: American Society of Hematology
Due Dates (Anticipated): March 2027 (full application deadline, projected)
Funding Amounts: $150,000 total; may be used over 1, 2, or 3 years per recipient's preference.
Summary: Supports independent investigators advancing hematology through basic, translational, clinical, or outcomes-based research.
Key Information: No more than two awards granted per medical school per cycle; eligibility restrictions apply.
The ASH Award for Research Careers in Hematology (ARCH) is designed to support independent investigators conducting impactful research in hematology. ARCH succeeds the ASH Bridge Grant program and is now decoupled from the NIH R01 mechanism, offering more direct support to researchers. The program’s primary aim is to make hematology research more accessible, particularly for investigators from at-risk communities, those addressing health disparities, and researchers with limited funding opportunities. Supported research may be basic, translational, patient-oriented, or outcomes-based, and the program maintains rigorous scientific review and programmatic priorities.